Assignee
ATOGEN CO LTD
KR·5 granted patents·3 pending applications·2 citations·filing 2015–2025
Top patents by PatentIndex Score
8 records- 0182US11318178B2Lactobacillus reuteri ATG-F4 strain having function of enhancing dopamine secretion and pharmaceutical composition comprising same for prevention or treatment of psychopathyATOGEN CO LTD·Filed 2019·Granted May 3, 2022·2 cites·3 claims
- 0268US12157882B2Lactobacillus plantarum strain ATG-K2, ATG-K6 or ATG-K8, and composition for preventing or treating vaginitis comprising sameATOGEN CO LTD·Filed 2021·Granted Dec 3, 2024·0 cites·3 claims
- 0364US11447741B2Lactobacillus plantarum strain ATG-K2, ATG-K6 or ATG-K8, and composition for preventing or treating vaginitis comprising sameATOGEN CO LTD·Filed 2019·Granted Sep 20, 2022·0 cites·7 claims
- 0463US2025222049A1Composition for preventing or treating lipid-related metabolic diseases, comprising lactobacillus plantarum atg-k2 or atg-k6ATOGEN CO LTD·Filed 2025·Application pending·0 cites
- 0556US2023201282A1Composition for preventing or treating lipid-related metabolic diseases, comprising lactobacillus plantarum atg-k2 or atg-k6ATOGEN CO LTD·Filed 2021·Application pending·0 cites
- 0652US12514886B2Composition comprising Lactobacillus reuteri ATG-F4 for prevention or treatment of muscular disorderATOGEN CO LTD·Filed 2019·Granted Jan 6, 2026·0 cites·3 claims
- 0748US2022143112A1Novel bifidobacterium longum strain or cosmetic composition comprising sameATOGEN CO LTD·Filed 2019·Application pending·0 cites
- 0832US10405569B2Lanctobacillus plantarum HAC01 strain having anti-inflammatory efficacy and metabolic disease alleviating efficacy and use thereofATOGEN CO LTD·Filed 2015·Granted Sep 10, 2019·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when ATOGEN CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →